All the new compounds successfully tested in preclinical phase

give new hope for better anticancer treatment.

KINETO Lab Ltd. is an acknowledged expert providing tailored and unique methods to identify and validate new drug targets and to evaluate in vitro and in vivo activity of anticancer drugs in the preclinical drug discovery through cell line-based screening procedures using in vitro and in vivo assays, and patient-derived tumor models.

We believe that our extensive experience and specific knowledge in drug development can help in successful and effective tests of your developmental conception.